Identification of alternative mechanisms of resistance to FGFR inhibitor treatment in FGFR1-amplified large cell compared to FGFR1-amplified small cell lung cancer models

被引：1
|
作者：
Jovcheva, Eleonora [1 ]
Ogata, Souichi [1 ]
Van De Ven, Kelly [1 ]
Paulussen, Caroline [1 ]
Van de Weyer, Inez [1 ]
Wolf, Hans D. [1 ]
Ceulemans, Hugo [1 ]
McClue, Steve [2 ]
Vialard, Jorge [1 ]
Perera, Timothy [1 ]
机构：
[1] Janssen, Beerse, Belgium
[2] Janssen, High Wycombe, Bucks, England
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-LB-329
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
329
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer
    Malchers, Florian
    Ercanoglu, Meryem
    Schuette, Daniel
    Castiglione, Roberta
    Tischler, Verena
    Michels, Sebastian
    Dahmen, Ilona
    Braegelmann, Johannes
    Menon, Roopika
    Heuckmann, Johannes M.
    George, Julie
    Ansen, Sascha
    Sos, Martin L.
    Soltermann, Alex
    Peifer, Martin
    Wolf, Juergen
    Buettner, Reinhard
    Thomas, Roman K.
    CLINICAL CANCER RESEARCH, 2017, 23 (18) : 5527 - 5536
  • [2] Missing the Mark in FGFR1-Amplified Squamous Cell Cancer of the Lung
    Paik, Paul K.
    Rudin, Charles M.
    CANCER, 2016, 122 (19) : 2938 - 2940
  • [3] FGFR antagonist induces protective autophagy in FGFR1-amplified breast cancer cell
    Chen, Yi
    Xie, Xiaoyan
    Li, Xinyi
    Wang, Peiqi
    Jing, Qian
    Yue, Jiaqi
    Liu, Yang
    Cheng, Zhong
    Li, Jingyi
    Song, Haixing
    Li, Guoyu
    Liu, Rui
    Wang, Jinhui
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 474 (01) : 1 - 7
  • [4] Resistance mediated by alternative receptor tyrosine kinases in FGFR1-amplified lung cancer
    Adachi, Yuta
    Watanabe, Kazuyoshi
    Kita, Kenji
    Kitai, Hidenori
    Kotani, Hiroshi
    Sato, Yuki
    Inase, Naohiko
    Yano, Seiji
    Ebi, Hiromichi
    CARCINOGENESIS, 2017, 38 (11) : 1063 - 1072
  • [5] A New Combination Therapy for FGFR1-Amplified Lung Cancer
    Yang, Z.
    Liang, S.
    Zheng, B.
    Chen, C.
    Peng, R.
    Schmid, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1220 - S1220
  • [6] FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
    Hong Yuan
    Zi-Ming Li
    Jiaxiang Shao
    Wen-Xiang Ji
    Weiliang Xia
    Shun Lu
    Journal of Experimental & Clinical Cancer Research, 36
  • [7] FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
    Yuan, Hong
    Li, Zi-Ming
    Shao, Jiaxiang
    Ji, Wen-Xiang
    Xia, Weiliang
    Lu, Shun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [8] Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398.
    Nogova, Lucia
    Sequist, Lecia V.
    Cassier, Philippe Alexandre
    Hidalgo, Manuel
    Delord, Jean-Pierre
    Schuler, Martin H.
    Lim, Wan-Teck
    Camidge, D. Ross
    Buettner, Reinhard
    Heukamp, Lukas Carl
    Gardizi, Masyar
    Scheffler, Matthias
    Kambartel, Kato
    Ringeisen, Francois Philippe
    Sen, Suman
    Isaacs, Randi
    Joannaert, Maud
    Lefebvre, Caroline
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Exploring the in vitro and in vivo activity of lucitanib in FGFR1-amplified lung cancer models
    Bello, Ezia
    Chila, Rosaria
    Guffanti, Federica
    Zangarini, Monique
    Ceriani, Laura
    Zucchetti, Massimo
    Chaudi, Saba
    Pierrat, Marie-Jeanne
    Jacquet-Bescond, Anne
    Damia, Giovanna L. M.
    CANCER RESEARCH, 2014, 74 (19)
  • [10] An FGFR1/2 degrader overcomes antiestrogen resistance in ER+/FGFR1-amplified breast cancer
    Uemoto, Yasuaki
    Lin, Chang-Ching
    Servetto, Alberto
    Wang, Bingnan
    Ye, Dan
    Napolitano, Fabiana
    Patel, Hima Milan
    Formisano, Luigi
    Chica-Parrado, M. Rosario
    Bikorimana, Emmanuel
    Mendiratta, Saurabh
    Chen, Chuo
    Hanker, Ariella
    Arteaga, Carlos
    CANCER RESEARCH, 2024, 84 (09)
12345